Vimarsana
Biggest News Aggregation in the World

Cassava Science News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cassava Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cassava Science Today - Breaking & Trending Today

Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ - Vimarsana News

Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ

End-of-day, Thursday, May 2, 2024, Will be the Last and Final Day to Trade SAVAW Warrants on NASDAQ.Monday, May 6, 2024, Will be the Last and Final Day to Cash-Exercise SAVAW Warrants.‘Notice of...

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials - Vimarsana News

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

An Independent Data and Safety Monitoring Board Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials. The DSMB Recommended Both Phase 3 Trials...

Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report - Cassava Sciences (NASDAQ:SAVA) - Vimarsana News

Alzheimer's Drug Trial Results Questioned After 'Damning' FDA Inspection Report - Cassava Sciences (NASDAQ:SAVA)

The credibility of the clinical trial results for an experimental Alzheimer's drug has been called into question following a critical inspection report by the Food and Drug Administration.

Integrity Issues Rampant in AD Research, Say Investigators - Vimarsana News

Integrity Issues Rampant in AD Research, Say Investigators

Investigative sleuths say the rewards are high while consequences are almost nonexistent, all while investigations take years to complete.

Cassava Sciences Reports Full-year 2023 Financial Results - Vimarsana News

Cassava Sciences Reports Full-year 2023 Financial Results

$121.1 Million In Cash and Cash Equivalents at December 31, 2023, With an Additional $21.8 Million Raised In 2024 From Exercise of Warrants.A Total of Over...